Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

This study has been completed.
Sponsor:
Collaborator:
Catalyst Pharmaceutical Partners, Inc
Information provided by:
New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT00527683
First received: September 10, 2007
Last updated: April 7, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
No publications provided by New York University School of Medicine

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):